Toggle Nav
Close
  • Menu
  • Setting

NEO214

Catalog No.
BA3664
NEO214, an autophagy inhibitor, is a covalent coupling of a PDE4 inhibitor with perillyl alcohol with anticancer activity and blood-brain barrier (BBB) permeability.
Grouped product items
SizePriceStock Qty
5mg
$135.00
Ship with 10-15 days
10mg
$225.00
Ship with 10-15 days
25mg
$495.00
Ship with 10-15 days
50mg
$765.00
Ship with 10-15 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

NEO214 is an autophagy inhibitor, a covalent coupling of a PDE4 inhibitor with perillyl alcohol, with anticancer activity and blood-brain barrier (BBB) permeability.NEO214 prevents autophagy-lysosomal fusion, which blocks autophagic flow and triggers cell death in glioma cells. The process involves activation, and (transcription factor EB) aggregation.NEO214 inhibits macroautophagy/autophagy in glioblastoma cells and has the potential to overcome chemoresistance in glioblastoma.

Chemical Properties

Physical AppearanceAn oil
Storage-20°C
M.Wt453.57
Cas No.1361198-80-2
FormulaC27H35NO5
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.